All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Occult HBV Infection-25521058

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	25521058	E164V	S	S	Occult HBV Infection	G R I L	View
2	25521058	G145S	S	S	Occult HBV Infection	G R I L	View
3	25521058	M133T	S	S	Occult HBV Infection	G R I L	View
4	25521058	P120T	S	S	Occult HBV Infection	G R I L	View
5	25521058	P127S	S	S	Occult HBV Infection	G R I L	View
6	25521058	Q129R	S	S	Occult HBV Infection	G R I L	View
7	25521058	T126I	S	S	Occult HBV Infection	G R I L	View
8	25521058	T126S	S	S	Occult HBV Infection	G R I L	View
9	25521058	T131N	S	S	Occult HBV Infection	G R I L	View
10	25521058	T143S	S	S	Occult HBV Infection	G R I L	View
11	25521058	V168F	S	S	Occult HBV Infection	G R I L	View
12	25521058	Y161F	S	S	Occult HBV Infection	G R I L	View
13	25521058	Y161S	S	S	Occult HBV Infection	G R I L	View
14	25521058	E146V	S	S	Occult HBV Infection	G R I L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.